Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma × Curettage × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 4 Chalazion 2 Recurrence 1 Pilonidal Sinus 1 Pain 1 Endometrial Neoplasms 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Squamous Cell 1 Bone Neoplasms 1 Bone Cysts 1

Interventions

Ifosfamide 4 Gemcitabine 4 Filgrastim 4 Docetaxel 4 Proton Therapy 3 Doxorubicin 3 regorafenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tazemetostat 1 tanespimycin 1 spartalizumab 1 resiquimod 1 poly ICLC 1 perifosine 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996747 2016-12-22

CONDRO1

Istituto Ortopedico Rizzoli

Bone Neoplasms, Chondroma, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡